Patents: no supplementary protection certificate for second medical use

http://www.twobirds.com/en/patenthub/shared/articles/2020/global/no-supplementary-protection-certificate-for-second-medical-use

The European Court of Justice (ECJ) has held that a supplementary protection certificate (SPC) cannot be granted for a different application of the same product for which an earlier marketing authorisation (MA) had been granted.

07 September 2020

The end of the road for SSPPU and the license point argument?

http://www.twobirds.com/en/patenthub/shared/articles/2020/global/the-end-of-the-road-for-ssppu-and-the-license-point-argument

With the rise of IoT and, in particular, the increased importance of vehicle connectivity, the last few years have seen an increase in arguments that the licence point and royalty basis for telecoms Standard Essential Patents ("SEP") should be at the ...

03 September 2020

Who is leading 5G development? – 2020 update

http://www.twobirds.com/en/patenthub/shared/articles/2020/global/who-is-leading-5g-development-2020-update

The twoBirds Pattern team (Bird & Bird’s patent intelligence offering) have published a new infographic on the difficulties in charting the leadership of companies in the 5G Standard Essential Patent (SEP) industry.

01 September 2020

UK Supreme Court rules on FRAND approach in Unwired Planet and Conversant

http://www.twobirds.com/en/patenthub/shared/articles/2020/uk/uk-supreme-court-rules-on-frand-approach-in-unwired-planet-and-conversant

The long awaited decision from the UK Supreme Court was handed down on 26 August 2020. Lord Hodge gave the summary of the judgment by video: it can be seen here . A 54 page judgment has been handed down.

26 August 2020

Patents: invalidity for insufficiency across broad range of products claimed

http://www.twobirds.com/en/patenthub/shared/articles/2020/uk/patents-invalidity-for-insufficiency-across-broad-range-of-products-claimed

The Supreme Court has held that two patents for a transgenic mouse used for the development of human antibodies were invalid for insufficiency.

05 August 2020